APA (7th ed.) Citation

Rui, M., Wang, Y., Wei, Q., & You, J. H. S. HRR deficiency-guided use of talazoparib plus enzalutamide in patients with metastatic castration-resistant prostate cancer: A cost-effectiveness analysis. SAGE Publishing.

Chicago Style (17th ed.) Citation

Rui, Mingjun, Yingcheng Wang, Qiran Wei, and Joyce H. S. You. HRR Deficiency-guided Use of Talazoparib Plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: A Cost-effectiveness Analysis. SAGE Publishing.

MLA (9th ed.) Citation

Rui, Mingjun, et al. HRR Deficiency-guided Use of Talazoparib Plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: A Cost-effectiveness Analysis. SAGE Publishing.